AeroClean Technologies, Inc. (NASDAQ: AERC) is an advance pathogen purification technology company, which is focused on the research, development and commercialization of air hygiene products. Shares of the purification technology company skyrocketed 100% during trading on Monday, June 6, 2022. Over the past three months, AeroClean has seen average daily volume of 154,740 shares. However, volume of 69.01 million shares or dollar volume of around $327.8 million, exchanged hands during the trading session.
Shares of AeroClean Technologies surged after the company announced that the U.S. Food and Drug Administration (FDA) has granted its 510(k) clearance for its Pūrgo™ device, which classifies it has a Class II Medical Device.
The clearance was provided after a thorough review of the company’s patent-protected UV-C LED air purification technology, which was proven to eliminate 99.99% of harmful airborne microorganisms, including viruses, bacteria and fungi. AeroClean will now look to increase its standing as a provider of medical-grade air purification and sanitization technology to heathcare facilities, businesses, government agencies, and more.
The Pūrgo™ device uses hospital-grade HEPA filtration along side germicidal UV irradiation in order to purify indoor air and spaces. Unlike standard filtration, the Pūrgo™ device focuses on are more fine particulates.
“We are proud to have been granted FDA clearance for AeroClean’s Pūrgo™ device and thank the administration for their in-depth review of our patented air hygiene technology,” said Jason DiBona, CEO of AeroClean. “As experts in indoor air quality, we aim to provide healthcare facilities, businesses, hospitality venues and government agencies with the highest medical-grade air purification and air sanitization technology. FDA clearance of our Pūrgo™ system, which is powered by our patented SteriDuct™ technology, represents a major step forward in significantly improving air quality where people meet, work and live.”
Disclosure: No position. Spotlight Growth has no relationships with any of the companies mentioned in this article and did not receive payment in any form for its creation. This is an opinion article and is not meant to be financial advise. We are not broker-dealers or investment professionals. Please conduct your own due diligence. For more information on our disclosures, please visit: https://spotlightgrowth.com/disclosures/
